Summary. Evidence exists that conceptuses alter endometrial protein secretion and modulate prostaglandin (PG) synthesis and secretion in cattle. The present study was designed to test the effect of bovine conceptus secretory proteins (bCSP) in general and the bovine trophoblast protein-1 complex (bTP-1) in particular on endometrial function. Endometrial explants from cyclic cows (N = 4) at Day 17 after oestrus were incubated for 24 h with 0, 4\m=.\8, 24 or 120 \g=m\gBSA/ml, 1 \g=m\gbTP-1/ml or 12\m=.\7\ g=m\ g bCSP/ml. Both bCSP and bTP-1 decreased (P < 0\m=.\005) release of radiolabelled macromolecules into medium and incorporation of radio-labelled precursors into tissue compared to BSA-treated tissues but not tissues treated with medium alone. Secretion of a protein of Mr = 14 900 was enhanced by bCSP treatment as compared to treatment with bTP-1 (P < 0\m=.\025). Both bCSP and bTP-1 decreased PGF secretion of explants (P < 0\m=.\01)compared to BSA. Overall, PGE-2 secretion by bCSP-and bTP-1\x=req-\ treated tissues did not differ from that of BSA cultures, but PGE-2 secretion was greater (P < 0\m=.\025) for bTP-1 than bCSP-treated endometrium. Cotyledonary microsomes from parturient cattle were utilized as a PG-generating system for the detection of inhibitors of PG synthesis. PGF synthesis by the generating system was decreased (P < 0\m=.\05)by 9% by cytosol from BSA-treated explants, whereas cytosol from bCSP\x=req-\ and bTP-1-treated explants decreased (P < 0\m=.\01) PGF synthesis by 42% and 35%, respectively. In summary, both bCSP and bTP-1 inhibit PGF secretion, induce synthesis of an intracellular inhibitor of PGF synthesis, and decrease protein synthesis and secretion. The bTP-1 complex therefore alters PG dynamics by explants in a manner that would function to prevent luteolysis and support the establishment of pregnancy.
Introduction
Continued secretion of progesterone from the corpus luteum (CL) is essential for maintenance of early pregnancy in the cow. Since prostaglandin (PG) F-2a from the uterine endometrium initiates regression of the CL in the absence of pregnancy (see Thatcher et ai, 1984) , the conceptus must attenuate PGF-2tx secretion if pregnancy is to be maintained. This concept is supported by several lines of evidence. During the oestrous cycle, episodic release of 13,14-dihydro-15-keto-PGF-2a (PGFM) is associated with declining progesterone concentrations (Thatcher et ai, 1986; Helmer & Britt, 1987) and presence of a viable embryo abolished episodic PGFM release (Kindahl et ai, 1976; Betteridge et ai, 1984) . Furthermore, release of PGFM in response to an oxytocin injection is similarly decreased during early pregnancy compared to the oestrous cycle (Lafrance & Goff, 1985) . The in-vitro secretion of PGF-2ct is also attenuated in cultured (Thatcher et ai, 1984; 'Reprint requests to: Dr W. W. Thatcher. et ai, 1988a) or perifused (Gross et ai, 1988b) endometrium from Day 17 of pregnancy compared to Day 17 of the oestrous cycle.
The conceptus exerts its effects through secretion of secretory macromolecules since intrauterine infusion of the total array of secretory proteins from Day-17 conceptuses (bovine conceptus secretory proteins; bCSP) into cyclic cattle was associated with an attenuation in the episodic release of PGF-2a (Knickerbocker et ai, 1986b) and an extension of the interoestrous interval. In cyclic cattle, injection of oestradiol-17ß will induce release of PGF-2a from the uterus (Knickerbocker et ai, 1986c; Thatcher et ai, 1986) , and intrauterine infusion of bCSP from Day 15 to 18 after oestrus attenuates this release (Knickerbocker et ai, 1986a) . Treatment of endometrial expiants with bCSP also reduces PGF-2a secretion in vitro (Gross et ai, 1988a) .
It was suggested by Thatcher et ai (1985) that secretory proteins of the conceptus stimulate an endometrial protein that inhibits PGF-2tx synthesis. Evidence has accumulated to support this concept: a protein in endometrial homogenates from cyclic cows can inhibit prostaglandingenerating enzymes and this activity is increased during early pregnancy (Basu & Kindahl, 1987; Gross et ai, 1988c) and can be enhanced in endometrial expiants by culture with bCSP (Gross et ai, 1988a) . The conceptus molecules that act to cause these changes in prostaglandin metabolism are probably the bovine trophoblast protein-1 (bTP-1) complex of proteins. These molecules are a group of interferon-like, AMinked glycoproteins that arise from transcription of at least three mRNAs and exist as two size classes of differentially glycosylated proteins (Anthony et ai, 1988; Helmer et ai, 1988; Imakawa et ai, 1989) . They show immunological cross-reactivity (Helmer et ai, 1987; Godkin et ai, 1988) and cDNA sequence homology (Imakawa et ai, 1989) with oTP-1, the protein secreted by the conceptus that blocks luteal regression in the sheep (see Thatcher et ai, 1988 , for review). Most importantly, intrauterine infusion of bTP-I delayed luteolysis (Helmer et ai, 1989).
The major objective of this experiment was to determine whether bTP-1 acts to block luteolysis by altering endometrial prostaglandin secretion and, if so, whether it acts so by inducing synthesis of the endometrial prostaglandin synthesis inhibitor previously reported to be present in pregnant endometrium and enhanced by in-vitro treatment with bCSP (Gross et ai, 1988a, c ). An additional objective was to evaluate the effect of bTP-1 on endometrial protein secretion. Such alteration could represent a mechanism by which the conceptus regulates its environment. Evidence for changes in protein secretion is based on findings that in-vitro treatment of bovine endometrium with bCSP alters protein secretion (Gross et ai, 1988a) , and findings that oTP-1 can alter protein secretion in sheep endometrium (Godkin et ai, 1984; Vallet et ai, 1987 [5,6,8,12,14,15-3H] (Helmer et ai, 1987) . Conceptuses were cultured for 72 h with MEM being replaced every 24 h (for con¬ ditions see Helmer et al., 1989 Preparation ofsamplesfor incubation with endometrium. Total bCSP from the first, second and third 24 h ofculture were pooled and dialysed against 10 mM-sodium phosphate, pH 7-4 with 0-9% (w/v) NaCl (PBS) and concentrated by placing the sample in dialysis tubing packed in Aquacide II as described by Helmer et al. (1989) . This resulted in a final concentration of 975 pg/ml. The amount of total protein contained within medium from the culture of a single conceptus for a 24-h period is defined as a culture equivalent; this was approximately 1-9 mg/culture following dialysis and concentration. Endometrial culture in the presence of bCSP was carried out with an amount of bCSP equivalent to 10% (w/v) of a culture equivalent (190 pg bCSP in 195 pi buffer).
The bTP-1 complex was purified as described previously by Helmer et al. (1989) . A stock concentration of 15 pg bTP-l/ml in 0-2M-NaPO4 pH 7-4 was attained and utilized at a final concentration of 1 pg/ml in medium for incubation with endometrium. Both bCSP and bTP-1 solutions were filter-sterilized (0-2 pm) before addition to incu¬ bations. Bovine serum albumin (BSA) was dissolved as a concentrated stock in MEM (0, 72, 360 and 1800 pg BSA/ml) and similarly sterilized.
In-vitro culture ofendometrial tissues. Brangus cows (N = 4) were observed for oestrus and slaughtered on Day 17 after oestrus (oestrus = Day 0). Reproductive tracts were recovered; endometrium from the uterine horn ipsilateral to the corpus luteum (CL) was isolated from myometrium, cut into 1-3 mm3 pieces and cultured as follows. For each cow, the following cultures were prepared in duplicate in 100-mm Petri dishes containing 500 mg tissue: (1) BSA: 0, 4-8,24and 120 pg/ml (100 µ of the 0, 72, 360 and 1800 pg BSA/ml MEM stock solutions added to 14ml MEM and 1 ml 0-2 M-NaP04, pH 7-4), (2) bCSP: 12-7 pg/ml (195 pi bCSP [190 pg] mixed with 800 pi 0-2 M-NaP04 and 14 ml MEM) or (3) bTP-1: 1 pg/ml ( 1 ml bTP-1 [15 pg] in 0-2 M-NaP04 mixed with 14 ml MEM). Each culture also included addition of arachidonic acid (0-2 mg in 01 ml MEM). Samples of medium (0-5 ml) were removed at 6, 12, 18 and 24 h of incubation.
An additional set of cultures was prepared from each cow except that 250 mg tissue were incubated in 60-mm Petri dishes in duplicate; one-half the tissue weight, medium volume and arachidonic acid dose per dish as used in the previously described cultures were utilized. These incubations were carried out in leucine-deficient (xOT) MEM supplemented with 50 pCi L-[4,5-3H]leucine. Samples of medium (0-25 ml) were taken at 6, 12, 18 and 24 h of incu¬ bation. At the end of incubations, tissue and medium were separated by centrifugation (3500 g, 30 min, 4°C), and each stored at -20°C until analysed. In all cases, incubations were carried out on a rocking platform at 39°C for 24 h in an atmosphere of 47-5% oxygen, 2-5% carbon dioxide and 50% nitrogen (v/v).
Assay for inhibition of prostaglandin synthesis. Cotyledonary microsomes prepared from parturient cattle and endometrial cytosolic supernatant from expiants after 24 h of culture (100 000 g) were prepared as described pre¬ viously (Gross et al., 1988c) . Cytosolic supernatants from endometrial cultures were obtained by pooling tissue from duplicate cultures (1 g total weight) and reconstituting the high-speed supernatant to 1 ml with potassium phosphate buffer, pH 7-5. Cotyledonary microsomes from parturient cattle were utilized as a prostaglandin-generating system for the detection of inhibitors to PG synthesis. The generating system (0-5 ml; 500 mg tissue equivalent) was incubated with 01 mg arachidonic acid (01 ml) and with 01 M-potassium phosphate buffer (0-4 ml, pH7-5) or endometrial cytosolic supernatant (0-4 ml; 400 mg tissue equivalent). Final incubation volume was brought to 2 ml with 01 Mpotassium phosphate buffer, pH 7-5. Incubations were conducted for 1 h at 39°C on a rocker platform. Incubations were terminated by addition of 0-25 ml ethanol. Samples were centrifuged (1500g) for 20 min at 4°C to pellet the ethanol-precipitated material. Supernatants were analysed directly for PGF using radioimmunoassay.
Radioimmunoassay procedures. Samples were assayed for PGF by radioimmunoassay (RIA) procedures described by Knickerbocker et al. (1986c) . The assay was modified to use an antibody supplied and characterized by Kennedy (1985) , and cross-reactivities of the PGF antiserum as well as assay validation were described previously by Gross et al. (1988a, c) . Cross-reactivity of the PGF antiserum for PGF-la was 94%, and so results of assays performed with this antiserum are referred to as PGF activity. Cross-reactivity of the PGF antiserum with other PGs were 2-4% for PGE-2; and <0T% for 13,14-dihydro-15-keto-PGF-2a, PGE-1, 6-keto-PGF-la and arachidonic acid. Interassay and intra-assay coefficients of variation were 11-3% and 12-4%, respectively.
A procedure to measure prostaglandin E-2 (PGE-2) was utilized with modifications from an earlier RIA pro¬ cedure and an antibody characterized by Lewis et al. (1978) . The assay was validated and cross-reactivities described by Gross et al. (1988a) . Cross-reactivities of the PGE-2 antiserum with PGs were 24% for PGE-1; 1-7% for PGF-2a; and <0T% for 13,14-dihydro-15-keto-PGF-2a, PGF-la, 6-keto-PGF-la and arachidonic acid. Interassay and intraassay coefficients of variation were 9-8% and 13-2%, respectively. For both PGF and PGE assays, single deter¬ minations of medium samples were made except for every 5th sample, in which duplicate determinations were made to monitor intra-assay variation.
Radiolabelled protein incorporation. Incorporation of radiolabelled leucine into secreted (medium) and intracellular (tissue) proteins was determined by trichloroacetic acid (TCA) precipitation. Tissue from incubations with [3H]leucine was solubilized in 50 mM-Tris-acetate buffer (1 ml buffer/250 mg tissue) containing 1 mM-phenylmethylsulphonylfluoride, 1 mM-ethylenediamine-tetraacetic acid (EDTA) and 2% (v/v) Nonidet P-40. Duplicate samples (005 ml) of medium and solubilized tissue were each placed and dried onto Whatman 3MM paper that previously had been saturated with 20% TCA (w/v). Precipitation of proteins onto the filter paper and removal of non-proteinaceous compounds was accomplished by serial washing of filter paper with 20% and 5% TCA followed by 95% ethanol as described by Mans & Novelli (1961 separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using 12-5% (w/v) polyacrylamide gels and the buffer system of Laemmli (1970 
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Data on incorporation of radiolabel into secreted proteins were analysed using the model components of treat¬ ment (medium, BSA, bCSP, bTP-1), cow, treatment cow, replicate (treatment cow), time (6, 12, 18, 24 209,198,206 and 193 ng/ml [s.e.m.
= 9], respectively). The 4-8 µg BSA/ml treatment group was used for control comparisons in subsequent analyses because this concentration of BSA most closely approximated that of bCSP (12-7 µg/ml) and bTP-1 (1 µg/ml) treatment groups. Secretion of PGF by endometrial expiants from cyclic cattle (Table 3) increased with time (P < 001) and secretion was decreased by bCSP and bTP-1 treatments as compared to BSA controls (P < 0005). Secretion of PGF did not differ between bCSP-or bTP-1-treated expiants. Orthogonal contrasts comparing secretion of PGE-2 by endometrial expiants treated with bCSP and bTP-1 to that secreted by BSA-treated expiants revealed no significant effect. However, expiants treated with bTP-1 did secrete more PGE-2 (P < 0005) than did those treated with bCSP (Table 3) . A significant treatment time interaction was detected due to an amplification of PGE-2 endo¬ metrial secretion between 12 and 24 h in response to bTP-1 (P < 0005). Mean secretion of PGE-2 by animals treated with bTP-1 or bCSP was not different when compared to the BSA control group based upon a Dunnett's t test for comparing multiple treatments to a single control (Steele & Torrie, 1980) . 9%) , whereas cytosol from bCSP-and bTP-1-treated expiants markedly decreased (P < 001) PGF synthesis (2-25, 42% and 2-575, 35%, respectively). The reduction in PG synthesis by the generating system caused by adding cytosol from expiants treated with bCSP was not significantly different from the inhibition caused by cytosol from bTP-1-treated tissue.
Incorporation of radiolabel into macromolecules
For all treatments, accumulated incorporation of radiolabel into secreted proteins increased (P < 001) with time of incubation. Incubation of endometrial expiants with 4-8, 24 or 120 µg BSA/ ml significantly increased (P < 001) incorporation of radiolabelled precursors into secreted (479 235; 483 proteins, respectively). However, the effect of BSA was not concentrationdependent and the 0 and 4-8 µg BSA/ml doses were utilized as controls to compare to other treatment responses. Treatment of endometrial expiants from cyclic cows with bCSP or bTP-1 significantly decreased (P < 0005) incorporation of radiolabel into secreted proteins compared to treatment with 4-8 µg BSA/ml (51 -7% and 56-2% reduction at 24 h, respectively; Table 4 ). This effect also caused a treatment time interaction (P < 001). The decrease in incorporation was not significant when comparing expiants treated with bCSP and bTP-1 to expiants treated without any BSA (90% and 17-7% reduction at 24 h, respectively; Table 4 ). jbCSP and bTP-1 < medium; < 010.
Incorporation of radiolabel into tissue proteins at the end of the 24-h incubation (Table 4 ) was similarly decreased (P < 0005) for bCSP-and bTP-1-treated expiants compared to expiants treated with 4-8 µg BSA/ml (P < 001; 64-2% and 66-6% reduction at 24 h for bCSP and bTP-1, respectively) and when compared to expiants treated without BSA (P < 010; 22-5% and 27-7% reduction at 24 h, respectively).
Analysis of endometrial secretory proteins by SDS-PAGE Typical patterns of radiolabelled secretory proteins present in endometrium-conditioned cul¬ ture medium are shown in Fig. 1 and whose intensity on fluorographs was greater for endometrium treated with bCSP than for endometrium given other treatments. The intensity of this band on fluorographs was quantified using densitometry. Total density associated with this protein on a per culture basis was higher for bCSP-treated endometrium (mean 400 units) than for untreated endometrium (mean 12-5 units) or endometrium treated with BSA (mean 21-3 units) or bTP-1 (mean 140 units; pooled s.e.m. = 2-6). These differences resulted in a significant (P < 0-025) orthogonal difference for bCSP-treated cultures than for bTP-1-treated cultures. There was a cow treatment interaction (P < 0001) that resulted because bCSP enhanced the secretion of the proteins in 3 of 4 animals. Fig. 1 . Fluorograph of proteins secreted by bovine endometrium cultured without treatment (Con), with 4-8 µg BSA/ml (BSA), 12-7 pg bovine conceptus secretory proteins/ml (bCSP) or 1 µg bTP-1/ml (bTP-1). Equal amounts of non-dialysable radioactivity were analysed in each lane by SDS-PAGE using 12-5% (w/v) polyacrylamide gels under reducing conditions. Shown are the results from one representative animal. The arrow identifies a protein of Mr 14 900 that was enhanced in intensity by treatment with bCSP.
Discussion
Results from the present experiment support the hypothesis (Thatcher et ai, 1985) that bCSP causes maintenance of the CL by inducing an inhibitor of prostaglandin-synthesizing enzymes. The induction of the prostaglandin synthesis inhibitor seen in the present experiment probably accounted for the decrease in secretion of PGF caused by bCSP and bTP-1. This response is in agreement with results of Gross et ai (1988a) whereby culture of endometrium from cyclic cows with bCSP reduced PGF secretion and enhanced activity of the prostaglandin synthesis inhibitor.
Likewise, in-vivo results indicated that intrauterine infusion of bCSP reduced PGF secretion (Knickerbocker et ai, 1986a, b) . In the present study, bTP-1 lowered PGF secretion in vitro and induced the presence of the prostaglandin synthesis inhibitor. Furthermore, intrauterine infusion of bTP-1 extended interoestrous interval and attenuated PGF secretion (Helmer et ai, 1988b (1988) demonstrated that PGF is secreted primarily by epithelial cells of bovine endometrium, whereas PGE-2 is secreted primarily by stromal cells. Therefore, one major action of bTP-1 would appear to be on the epithelium since PGF secretion was inhibited via induction of an inhibitor to PG synthesis. Since PGE-2 production from the epithelium is small compared to that from the stroma, it would not be unexpected that bTP-1 would have a different and minor effect on the net secretion of PGE-2 by the endometrium. Collectively, these data suggest that the intracellular endometrial prostaglandin synthesis inhibitor is present in the epithelium rather than the stromal cells of the endometrium. Future studies are needed to examine the effects of bTP-1 on isolated bovine epithelial and stromal cells during the oestrous cycle and pregnancy. Differential regulation of PGF and PGE-2 secretion is supported by the endometrial perfusion studies of Gross et al. (1988b) in which PGF secretion was reduced in pregnant endometrial tissues but PGE-2 secretion was not.
Incorporation of [3H]leucine into endometrial secretions and tissue proteins was reduced by bCSP and bTP-1 as compared to BSA-treated tissues. This reduction was not evident when compared to incorporation responses of tissues incubated with medium alone. The reduction in incorporation of radiolabel into tissue proteins indicated that synthesis, as well as secretion, were reduced and agrees with the results of Gross et ai (1988a) . This effect would appear to represent a mechanism whereby the developing conceptus directly influences the endometrial synthesis of protein during pregnancy and confirms the finding that the uterine endometrium appears to be a primary target of bTP-1. As found previously (Gross et ai, 1988a) , bCSP enhanced the secretion of a protein having a molecular weight of 14 900. This protein is also elevated in secretion from endometrium from pregnant cows as compared to cyclic ones (Bartol et ai, 1981 (Bartol et ai, , 1985 Geisert et ai, 1988; Gross et ai, 1988a 
